8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Verve Therapeutics Inc. (VERV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 6,904,050 | $38,938,842 | +963% | 1.31% |
| 2. | Casdin Capital Eli Casdin | 3,995,571 | $22,535,020 | 1.49% | |
| 3. | Millennium Management Israel Englander | 3,919,131 | $22,103,899 | -22% | 0.01% |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 3,789,379 | $21,372,097 | +58% | 0.12% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,691,530 | $9,540,229 | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.26 | 76,000 | 342,509 | 2024-05-14 | Filing | ||
| $10.00 | 1,800,000 | 1,800,000 | 2023-12-01 | Filing | ||
| $12.15 | 10,000 | Director | 18,700 | 2022-05-12 | Filing | |
| $21.38 | 4,000 | Director | 8,700 | 2022-03-15 | Filing | |
| $32.10 | 4,000 | Officer | 170,722 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.15 | 9,822 | 346,686 | 2025-04-02 | Filing | ||
| $4.15 | 2,777 | 17,420 | 2025-04-02 | Filing | ||
| $4.15 | 2,681 | 348,828 | 2025-04-02 | Filing | ||
| $4.15 | 3,235 | 14,226 | 2025-04-02 | Filing | ||
| $4.15 | 3,350 | 13,280 | 2025-04-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 103,707 | $473,931 | 0% | |
| 2. | 54,492 | $249,028 | 0.27% | |
| 3. | 27,206 | $124,331 | 0% | |
| 4. | 10,000 | $45,700 | 0.01% | |
| 5. | 33,539 | $7,339 | 0.04% |
News See All
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors. For the risk averse investors that are looking for steady payouts or long term stability, value and dividend paying stocks are the way to go.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
12 Best Short Squeeze Stocks to Buy Now
Plug Power, Inc. (NASDAQ:PLUG), Cinemark Holdings, Inc. (NYSE:CNK), and Allogene Therapeutics, Inc.
Top 10 CRISPR Stocks To Buy
Molecular biology, genetics, and genomics are in a significant period in history where technical capabilities and methods enable the editing of specific DNA segments and base pairs in living organisms...
Cathie Wood Is Loading Up On These 12 Stocks
If there's one thing that can be said for certain in today's highly volatile environment, it's that 2022 has not been a good year for Cathie Wood. Ms.
Billionaire Hedge Funds
